https://nl.marketscreener.com/koers/aandeel/FIBROGEN-INC-18537026/nieuws/Fibrogen-kondigt-topresultaten-aan-van-de-Fase-1-Monotherapie-studie-van-FG-3246-bij-patienten-met-46345847/?utm_source=telegram&utm_medium=social&utm_campaign=share